Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Furosemide versus furosemide + indapamide for congestive heart failure
IRCT20220809055644N1Phase 3Completed
- Sponsor
- Guilan University of Medical Sciences
- Start
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of furosemide and indapamide in heart failure (HF) (2 arms), sponsored by Guilan University of Medical Sciences. Primary endpoints: Reducing congestion and Evaluation of electrolyte disorders. Started Aug 2022; status: completed.
02
Drugs
furosemideindapamide
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on IRCT20220809055644N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220809055644N1.